Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis

被引:1
|
作者
Watson, HR
Robb, R
Belcher, G
Belch, JJF
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland
[2] Takeda Europe, R&D Ctr, Drug Safety, Frankfurt, Germany
关键词
Raynaud's phenomenon; systemic sclerosis; season; temperature;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective, Patients with systemic sclerosis (SSc) were assessed for 12 months to quantify the seasonal variation in Raynaud's phenomenon (RP) in patients with an underlying connective tissue disease. Methods. Eighteen patients with SSc (17 limited, 1 diffuse type) were studied. Raynaud's attacks were recorded in a daily diary for four 2-week periods at 3 month intervals, Daily number and duration of attacks and overall severity of RP were calculated for each 2-week period. Mean daily temperatures, measured and perceived, were obtained for each period. Results, In winter, patients had a mean of 2.9 attacks/day (SD +/- 1.1), daily duration 70 minutes (SD +/- 48) and a severity of score of 4.1 (SD +/- 2.0) out of 10. All 3 variables correlated with ambient outdoor temperature and varied significantly over the 12 months (p < 0.001) with mean reductions of 48, 50, and 56% respectively from winter to summer. Only 3 of 18 patients reported no attacks during the summer period. The mean measured and perceived outdoor temperatures increased from winter to summer by 10.6 and 14.3 degrees C, respectively. Conclusion. For patients with SSc, RP is a problem throughout the year. Symptoms may be reduced by about 50% in the summer months, but few patients experience complete relief.
引用
收藏
页码:1734 / 1737
页数:4
相关论文
共 50 条
  • [31] Raynaud phenomenon and digital ulcers in systemic sclerosis
    Michael Hughes
    Yannick Allanore
    Lorinda Chung
    John D. Pauling
    Christopher P. Denton
    Marco Matucci-Cerinic
    Nature Reviews Rheumatology, 2020, 16 : 208 - 221
  • [32] Raynaud phenomenon and digital ulcers in systemic sclerosis
    Hughes, Michael
    Allanore, Yannick
    Chung, Lorinda
    Pauling, John D.
    Denton, Christopher P.
    Matucci-Cerinic, Marco
    NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (04) : 208 - 221
  • [33] Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud's Phenomenon Secondary to Systemic Sclerosis
    Schiopu, Elena
    Hsu, Vivien M.
    Impens, Ann J.
    Rothman, Jennifer A.
    McCloskey, Deborah A.
    Wilson, Julianne E.
    Phillips, Kristine
    Seibold, James R.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (10) : 2264 - 2268
  • [34] Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: A pilot study
    Sambo, P
    Amico, D
    Giacomelli, R
    Matucci-Cerinic, M
    Salsano, F
    Valentini, G
    Gabrielli, A
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (10) : 2257 - 2262
  • [35] Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study
    Bixio, Riccardo
    Mastropaolo, Francesca
    Appoloni, Matteo
    Bertelle, Davide
    Bertoldo, Eugenia
    Morciano, Andrea
    Di Donato, Stefano
    Adami, Giovanni
    Viapiana, Ombretta
    Rossini, Maurizio
    Luca, Idolazzi
    CLINICAL RHEUMATOLOGY, 2024, : 299 - 304
  • [36] Raynaud's phenomenon (primary or secondary to systemic sclerosis). The usefulness of laser-Doppler flowmetry in the diagnosis
    Del Bianco, E
    Magini, B
    Muscarella, G
    Cappugi, P
    Lotti, T
    INTERNATIONAL ANGIOLOGY, 2001, 20 (04) : 307 - 313
  • [37] COMPARISON OF POSTOCCLUSIVE HYPEREMIA IN SYSTEMIC SCLEROSIS AND PRIMARY RAYNAUD'S PHENOMENON
    Gaillard-Bigot, F.
    Roustit, M.
    Blaise, S.
    Gabin, M.
    Cracowski, C.
    Seinturier, C.
    Imbert, B.
    Carpentier, P.
    Cracowski, J. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S74 - S74
  • [38] Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients
    Negrini, Simone
    Spano, Francesca
    Penza, Elena
    Rollando, Daniela
    Indiveri, Francesco
    Filaci, Gilberto
    Puppo, Francesco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (03) : 407 - 412
  • [39] Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis
    Sunderkoetter, C.
    Riemekasten, G.
    RHEUMATOLOGY, 2006, 45 : 33 - 35
  • [40] Neuronal Regulators and Vascular Dysfunction in Raynaud's Phenomenon and Systemic Sclerosis
    Fonseca, Carmen
    Abraham, David
    Ponticos, Markella
    CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (01) : 34 - 39